# AN2 Therapeutics, Inc.: Form 8-K, filed Aug 12, 2025

- Company: [AN2 Therapeutics, Inc.](/companies/antx.md) (CIK 1880438)
- Form: 8-K
- Filed: 2025-08-12
- Accepted by EDGAR: Aug 12, 2025, 16:02 ET
- Period: 2025-08-12
- Accession: 0000950170-25-107278
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1880438/000095017025107278/antx-20250812.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1880438/000095017025107278/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1880438/000095017025107278/antx-20250812.htm

Filed Aug 12, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-107278. Last ingested by Listed: Nov 6, 2026, 18:51 ET. No prices; not investment advice.